Endocrinology - A major breakthrough toward new treatments for Type 1 and Type 2 diabetes
Can't see this email? View it online
   
  Endocrinology  
  The latest endocrinology news from News Medical  
 Hitting rewind on the spread of pancreatic cancerHitting rewind on the spread of pancreatic cancer
 
News-Medical speaks to Linxiang Lan, a staff scientist at The Institute of Cancer Research, about a fundamental discovery that could pave way for new pancreatic cancer treatments.
 
   A major breakthrough toward new treatments for Type 1 and Type 2 diabetesA major breakthrough toward new treatments for Type 1 and Type 2 diabetes
 
A world-first study by Monash University, in Melbourne, Australia has discovered a pathway to the regeneration of insulin in pancreatic stem cells, a major breakthrough toward new therapies to treat Type 1 and Type 2 diabetes.
 
   Review: No clear evidence that serotonin levels are responsible for depressionReview: No clear evidence that serotonin levels are responsible for depression
 
After decades of study, there remains no clear evidence that serotonin levels or serotonin activity are responsible for depression, according to a major review of prior research led by UCL scientists.
 
 Research into a Cure for Diabetes
 
Research into a Cure for DiabetesManaging diabetes is a daily balancing act that demands continual care. Insulin treatment cannot perfectly replicate a healthy pancreas' physiologic function. This article explores the research into a cure for diabetes.
 
 
 Alternative therapy based on S100A9 protein improves metabolism of insulin-dependent diabetics
 
Alternative therapy based on S100A9 protein improves metabolism of insulin-dependent diabeticsPeople with a severe form of diabetes, where the beta cells of the pancreas do not produce or no longer produce enough insulin, have no choice but to inject themselves regularly with artificial insulin in order to survive.
 
 
 Surveillance program for high risk patients aids in early detection of pancreatic cancer
 
Surveillance program for high risk patients aids in early detection of pancreatic cancerSurveillance programs for people at high risk of developing pancreatic cancers can help detect precancerous conditions and cancers early, when they are most treatable, according to a new multicenter study directed by experts at the Johns Hopkins Kimmel Cancer Center.
 
 
 How has the COVID-19 pandemic impacted prescribing pancreatic enzyme replacement to people with unresectable pancreatic cancer?
 
How has the COVID-19 pandemic impacted prescribing pancreatic enzyme replacement to people with unresectable pancreatic cancer?Researchers evaluated the impact of the COVID-19 pandemic on the rates of pancreatic enzyme replacement therapy (PERT) prescribing in England.